The Hedgehog family of signaling molecules is conserved throughout evolution with three secreted proteins that have been identified in mammals: Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh). While these proteins differ in their tissue specificity, they all activate the same downstream signaling cascade including two transmembrane receptors-Patched1 and Smoothened, the family of Gli transcription factors, and other molecules involved in the signal transduction such as Fused, Suppressor of Fused (Sufu) and Costal2 (1) .
The Hedgehog pathway plays a crucial role in metazoan embryo patterning (1) . The most intensively investigated aspects of the Hedgehog pathway to this day include: establishment of ventral cell identity in the neural tube (2) , establishment of posterior identity in the developing limb bud (3) , and the pathway's roles in neoplastic transformation.
Inherited or acquired aberrations in components of the Hedgehog cascade result in various phenotypes including congenital anomalies (e.g. holoprosencephaly and Pallister-Hall syndrome) and various cancers, most frequently medulloblastoma, basal cell carcinoma, gastrointestinal cancers and rhabdomyosarcoma (4, 5) .
Recently, observations from different systems have suggested a role for Hedgehog signaling in the control of motility and migration of multiple cell types. Hedgehog has been shown to act as both a stimulant and an inhibitor of axonal migration (6, 7) . Hedgehog signaling blocks migration of neural crest cells in chick, but is required for migration of germ and tracheal cells in drosophila (8) (9) (10) . Similarly Hedgehog signaling is essential for yolk-sac and embryonic vasculogenesis (11, 12) , and enhances endothelial progenitor cellsmediated microvascular remodelling during wound healing (13) . Transfer of naked Shh cDNA into myocardial cells also enhanced the contribution of bone marrow-derived endothelial progenitor cells to myocardial neovascularization after acute and chronic myocardial ischemia (14) . Other studies, however, have failed to show a direct effect on endothelial cells in-vitro (15), implying that endothelial cells response to Hedgehog may be dependent on their differentiation status, developmental-age, and organ origin.
To elucidate the direct molecular consequences of Hedgehog signaling in endothelial cells we studied endothelial cells derived from the mouse embryo yolk sac at the time the Hedgehog signal is secreted from the visceral endoderm. We show that these endothelial cells as well as embryonic mouse fibroblasts respond directly to Hedgehog by transcriptional activation of multiple genes coding for proteins involved in migration and angiogenesis. We further show that Hedgehog signaling enhances in-vitro wound healing and that the neuropilin flavoprotein monooxygenases pathway mediates this effect. These findings suggest a molecular pathway mediating direct pro-migratory effect of Hedgehog on embryonic endothelial and fibroblast cells.
EXPERIMENTAL PROCEDURES
Reagents-Cyclopamine was kindly provided by Dale R. Gardner (U.S. Department of Agriculture's Poisonous Plant Research Laboratory) and suspended in 96% ethanol. It was used in 10 µM concentration in all assays.
Epigallocatechin Gallate (EGCG), (E4143; Sigma) was suspended in PBS.
Cell Culture-C166 endothelial cell line was isolated from the yolk sac of 12-day-old transgenic mouse embryos expressing multiple copies of the activated allele of the human cFes proto-oncogene (16) . The human embryonic kidney epithelial cell line 293T and mouse embryonic fibroblast cell lines NIH 3T3 and C3H/10T1/2 Clone 8 were obtained from ATCC (Manassas, VA; products' number: CRL-11268, CRL-1658 and CCL-226, respectively). The mouse embryonic fibroblast cell line BALB/c 3T3 clone A31 was kindly provided by Professor Gera Neufeld (Technion-Institute of Technology, Haifa, Israel). All cell lines were cultured in Dulbecco's modified Eagle's medium (41965-039; Gibco) supplemented with 10% fetal bovine serum (10270-106; Gibco). Primary Mouse Embryonic Fibroblasts (MEFs) were isolated directly from E12-E14 HS:ICR mouse embryos and maintained in DMEM supplemented with 10% fetal bovine serum. Cells were used up to six passages.
Generation of Conditioned media Shh conditioned media was produced as reported previously with few modifications (17) . Briefly, 293T cells were transiently transfected with Shh-N encoding plasmid (Shh-N is active secreted Shh), kindly provided by Philip A. Beachy, or with control pcDNA3.1 plasmid (V79020; Invitrogen) The growth media was collected 3 days posttransfection, centrifuged at 3000g for 10 minutes, and transferred through a 0.45µm filter to remove cell debris. The conditioned media potency was routinely checked on NIH 3T3 cells by studying the expression of Shh known transcriptional targets Gli1 and Patched by Quantitative real time PCR. When used to stimulate the Hedgehog pathway the conditioned media was diluted in the cells' maintenance media in different ratios as indicated in the text.
RNA interference and retroviral infections-virus mediated RNA interference was accomplished using the pRETRO-SUPER (pRS) construct kindly provided by Reuven Agami (18) . To generate pRETRO-SUPER targeting mouse Neuropilin1 (pRS-Nrp1), pRS was digested with BglΙΙ and HindΙΙΙ and the annealed oligos (5'gatccccGGAATGTTCTGTCGCTATGttcaa gagaCATAGCGACAGAACATTCCtttttggaaa 3' and 5'agcttttccaaaaaGGAATGTTCTGTCGCTAT GtctcttgaaCATAGCGACAGAACATTCCggg-3') were ligated into the vector. The 19 bps Neuropilin1 target sequences are indicated in capitals in the oligonucleotide sequence. To create mouse Neuropilin1 control RNA interference, mutations were generated in the target Nrp1 sequences and the new annealed oligos (5'-gatccccGTAAGGTTCTATCGCCATCttcaaga  gaGATGGCGATAGAACCTTAC-tttttggaaa-3' and 5'-agcttttccaaaaaGTAAGGTTCTATCGCCATCt ctcttgaaGATGGCGATAG-AACCTTACggg-3') were ligated into pRS to generate pRS-CONTROL.
293T cells were transiently transfected with pRS-CONTROL or pRS-Nrp1 retroviral plasmids, in combination with vectors coding for ecotropic retrovirus envelope and the gag and pol proteins. Forty eight hours post transfection the culture medium was filtered through a 0.45 µm filter and the viral supernatant was used for infection of C166 cells after addition of 8 µg/ml polybrene (H9268; Sigma). C166 cells were infected for 24 hours and allowed to recover for another 24 hours with fresh medium. Infected cells were selected with 10 µg/ml puromycin (ant-pr-1; InvivoGen) for a week and polyclonal puromycin resistant populations infected by Prs-CONTROL ('Nrp1 CONTORL' line) or pRS-Nrp1 ('Nrp1 nockdown' line) were established.
Quantitative real time PCR-Total RNA was extracted using Trisol reagent (15596-018; Invitrogen). cDNA was synthesized using Reverse -iT 1st strand synthesis kit (AB -0789/B; AB gene) with random decamers following the manufacturer's instructions.
The quantitative real time PCR reactions were performed using Master mix for Syber green (RT-SN2X-075+; EST Group) with cDNA equivalent to 100 ng of RNA (for each sample) using Applied Biosystems 7900HT prism real-time PCR instrument (Taqman; Perkin-Elmer/Applied Biosystems, Foster City, CA). PCR amplification included a first step of 10 minutes at 95°c followed by 40 cycles of amplification (95°c for 15 seconds and 60°c for 60 seconds). Ratio was calculated by dividing each gene expression with that of an internal standard in each sample.
Forward and reverse primers were designed in exon-intron junctions in order to avoid amplification from contaminating DNA.
For all the reactions primers designed to amplify beta-2 microglobulin gene were used as an internal control. Primers (Sigma): beta-2  microglobulin forward primer, 5'-GAG ACT  GAT ACA TAC GCC TGC AGA-3'; beta-2  microglobulin reverse primer, 5'-TCA CAT  GTC TCG ATC CCA GTA GA-3'; Gli1  forward primer, 5'-CAA GTG CAC GTT  TGA AGG CT-3'; Gli1 reverse primer, 5'-CAA CCT TCT TGC TCA CAC ATG Microarray design, hybridization and analysis-Seven plates of C166 cells with initial confluent of 2x10 4 cells/cm 2 were serum starved for 12 hours before initiation of the experiment with control conditioned media diluted 1 to 10 in media without serum (resulting in media containing 1% serum). One plate was then harvested and served as a baseline sample while the rest of the plates were washed and received fresh control conditioned media or a Shh conditioned media, again diluted 1 to 10 in media without serum, for an additional 12 hours or 24 hours. RNA was generated from the baseline sample and afterwards from the 12 hours and 24 hours time points. Each time point included one control treated sample and two Shh treated samples.
All experiments were performed using Affymetrix MOE430A oligonucleotide arrays, as described at http://www.affymetrix.com/support/technical/ datasheets/mogarrays_datasheet.pdf. Total RNA from each sample was used to prepare biotinylated target RNA, with minor 4 modifications from the manufacturer's recommendations (http://www.affymetrix.com/support/technical/ manual/expression_manual.affx).
Five µg of mRNA was used to generate first-strand cDNA by using a T7-linked oligo (dT) primer. After second-strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP (Enzo Diagnostics), resulting in approximately 300-fold amplification of RNA. The target cDNA generated from each sample was processed as per manufacturer's recommendation using an Affymetrix GeneChip Instrument System. Briefly, spike controls were added to 15 µg fragmented cRNA before overnight hybridisation. Arrays were then washed and stained with streptavidin-phycoerythrin, before being scanned on an Affymetrix GeneChip scanner. Additionally, quality and amount of starting RNA was confirmed using an agarose gel. After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. 3'/5' ratios for GAPDH and beta-actin were confirmed to be within acceptable limits (1.03-1.14 and 0.78-0.86, respectively), and BioB spike controls were found to be present on all chips, with BioC, BioD and CreX also present in increasing intensities. When scaled to a target intensity of 150 (using Affymetrix MAS 5.0 array analysis software), scaling factors for all arrays were within acceptable limits (0.63-0.84), as were background Q values and mean intensities (supplemental material table 1). Details of quality control measures can be found at http://eng.sheba.co.il/genomics.
Genes were filtered using MAS 5 algorithm. A list of 13,482 "valid" probe sets, representing probe sets with signal higher then 100 and detected as present (P) in at least one sample, was obtained (supplemental material table 2 -the data is represented to comply with "minimum information about a microarray experiment -MIAME" standards). The two samples treated with Shh for 24 hours were compared to the 24 hours control sample. The comparison generated a list of "active genes" in the Shh treated samples for 24 hours. Genes with an increased expression by at least in 1.5 fold compared to control were marked as "Increase" (I, p-value 0.0025) , or "Marginal Increase" (MI, p-value 0.003 ) if less then 1.5 fold. Similarly lower expression in the Shh group was labeled as "Decrease" (D, p-value 0.0025) or "Marginal Decrease" (MD, p-value 0.003). Hierarchical clustering was performed using Spotfire DecisionSite for Functional Genomics (Somerville,MA). Calculation of over represented functional classes were done using Ease (19) . Functional classifications with an 'Ease score' lower than 0.05 were marked as over-represented.
Protein analysis-for the purpose of detecting the Shh-N protein in the cell media, 25 µl from Shh-N or control conditioned media were mixed with lameli buffer and separated by 12% SDS-polyacrylamide gel electrophoresis. After electronic transfer onto nitrocellulose membranes (401385; Schleicher and Schuell) the blots were probed with antiShh, 5E1 hybridoma supernatant (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA).
Neuropilin1 immunoprecipitation and immunoblotting: Cells were lysed in a lysis buffer containing 50 mM Hepes (pH 7.4), 4 mM EDTA, 1% Triton x-100 and fresh protease inhibitor cocktail (1-836-145; Roche). 500µg of sample lysate were incubated with goat anti-Neuropilin1 antibody (c-19; Santa Cruz) and immune complexes were further precipitated using agarose conjugated protein A/G (sc-2003; Santa Cruz). Immunoprecipitated proteins were separated by 6% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The blots were probed with the same anti-Neuropilin1 antibody used for immunoprecipitation. The detection of the anti-Neuropilin1 antibody heavy chain was used as a conformation for equal addition of the antibody to the samples during precipitation. 293T cells transiently transfected with Neuropilin1 expressing vector (kindly provided by Gera Neufeld, TechnionInstitute of Technology, Haifa, Israel) served as a positive control for the immunoblotting.
Expression and purification of recombinant Shh-N protein-
Mouse Shh-N cDNA subcloned into a pET11d expression vector, forming a six histidine-tagged fusion protein, was kindly provided by Andrew P. McMahon. This plasmid was transformed into E.coli strain BL21 (DE3) PlysS (C6020-03; Invitrogen). Transformed bacteria were grown to an A550 of 0.5 and induced with 1 mM IPTG (I6758; Sigma) for a further 2 hours at 30°C. The bacteria were collected by centrifugation and stored at -70°C. Bacterial pellets were resuspended in lysis buffer (25 mM sodium phosphate, pH 8, 150 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 10 mM Imidazol (I5513; Sigma), Lysozyme 1mg/ml (1-243-004; Roche) and protease inhibitor cocktail). Afterward the lysate was sonicated (6 times 10 seconds bursts) and the homogenate was centrifuged at 14,000 g for 60 minutes, 4°C. 50% NTA-Ni agarose slurry (30210; Qiagen) was added to the homogenate (in 1:4 ratio) and mixed gently by shaking at 4°C for 60 minutes at 200 rpm. After a series of washes (25 mM sodium phosphate, pH 8, 300 mM NaCl, 0.5 mM DTT and 20 mM Imidazol) the His-Shh-N protein was eluted (25 mM sodium phosphate, pH 8, 300 mM NaCl, 0.5 mM DTT and 200 mM Imidazol) and dialyzed (against 5 mM sodium phosphate, pH 5.5, 150mM NaCl and 0.5mM DTT). Finally Glycerol was added to give 20% of the final volume and the protein was stored at -70°C. His-Shh-N was pure as characterized by Coomassie blue staining (B0149; Sigma) and immunoblut studies done similar as for the detection of Shh-N in the conditioned media. As reported before (20) , a dimeric form of the recombinant protein was formed spontaneously, probably by formation of disulfide bonds, giving a ~ 38 kD protein. His-Shh-N protein concentration was determined by Bicinchoninic acid, BCA, quantification assay (#23227; Pierce). The potency of the His-Shh-N protein was checked similar to Shh-N conditioned media. Scratch (wound) assay-migration through a wound introduced in cell monolayer was done similar to previous reports (21) . Briefly, C166, NIH 3T3 or MEF cells were grown to confluent and formed a monolayer covering the entire plate's surface. Cells were serum starved and treated with Shh or control conditioned media, with or without Cyclopamine (10 µM), according to expression studies. After 24 hours of treatment wound was created in the center of the cell monolayer by the gentle removal of the attached cells with a sterile plastic pipette tip. Debris was removed by PBS wash and the cells received fresh media with the same treatments as before. The ability of cells to migrate into the wound area was assessed after 24 hours by comparing the zero and 24 hours phase-contrast micrographs of several marked points along the wounded area at each plate. Chemical inhibitors, when used, were applied 30 minutes before wounding the cells. The percentage of non-recovered wound area was calculated by dividing the non recovered area after 24 hours by the initial wound area at zero time.
Trypan Blue Viability Assay-C166, treated with control or Shh conditioned media (diluted 1 to 10 in serum free media) for 48 hours, were incubated in the presence of 0.4% trypan blue solution (T8154; Sigma) in PBS for 60 seconds, and the number of viable cells was quantified. The experiments were repeated twice.
Statistical analyses-Student's t-test was carried out for comparison of paired mean experimental values.
RESULTS

C166, a mouse yolk sac endothelial cell line, responds to Sonic Hedgehog
The response of the yolk sac derived endothelial cell line C166 to Hedgehog signal was studied by monitoring the expression of well characterized primary target genes of the pathway, Gli1 and Patched1, using quantitative real time PCR technique. To stimulate the pathway, both Shh and control conditioned media were generated using 293T cells (Fig. 1A) . Exposure to Shh induced the expression of Gli1 and Patched1 (Fig. 1B) . C166 cells response to Shh was dose dependent, increased with the length of exposure and with the degree of cell confluence, and was further augmented by serum starvation (Fig. 1B) . As reported earlier, the transcriptional response to Shh was rather delayed, occurring at least 24 hours after exposure under these conditions (17) .
Shh induces migration of embryonic C166 and 3T3 cells in-vitro
The yolk sac phenotype of Smo -/-embryos suggests a defect in endothelial cell organization and migration (22) . To examine the functional effects of Shh on C166 cells we chose the in-vitro scratch (wound) assay. This assay is commonly used for testing the effects of pro and anti migratory agents on cultured cells (21) . Another advantage of this assay is that it is performed on a confluent cellular layer, a pre-condition for Hedgehog activity in-vitro (17, 23) . C166 cells were grown to confluence and treated with control or Shh conditioned media for 24 hours, in the presence or absence of the specific Hedgehog signaling inhibitor Cyclopamine (24) . After 24 hours a wound was introduced into the cell monolayer and fresh media, treated as before, were applied again. The migration of the cells into the wound area was assessed after 24 hours. Shh significantly enhanced the migration of C166 cells into the wounded area. This effect was eliminated by Hedgehog pathway specific inhibitor, Cyclopamine ( Fig. 2A) . Similar results were obtained on NIH 3T3 fibroblasts, a known Hedgehog responsive cell line (23) (Fig. 2B) , suggesting that the Shh promigratory effect is not restricted to endothelial cells.
The Hedgehog signal can also act as a mitogen in some systems (25). Although the wound assay was performed on confluent cells during serum starvation, we wished to rule out the possibility that the enhanced wound closure by Shh was not the result of a proliferative advantage conferred by Shh. Trypan blue viability counts showed no difference in the number of living cells between plates treated with Shh and control media (living cells counts, at the end of the experiment, were 2.5x10 6 and 2.8x10 6 in control and Shh treatments, respectively (P>0.05). These results were confirmed independently by MTT assay (supplementary figure 2) . Thus, the enhanced wound closure induced by Shh was caused by increased cell migration and not by increased cell number.
Characterization of the transcriptional response of C166 cells to Shh. To identify the transcriptional response to Shh in C166 cells an oligonucleotide microarray gene expression analysis was performed 12 and 24 hours after exposure (Fig. 3A) . These time points were chosen after optimizing the exposure conditions of C166 to Shh according to the parameters studied in Fig. 1 . Gli1 and Patched1 expression, as detected by both quantitative real time PCR and the genechip hybridization, was increased by treatment with Shh compared to control and served as an internal control for activation of the Hedgehog pathway in the gene expression array (Fig.  3B) . Non-supervised hierarchical clustering performed with Spotfire DecisionSite ™ revealed clear differences in the gene expression profiles of samples treated with Shh compared to controls after 24 hours. Consistent with the delayed transcriptional activity of Hedgehog signaling (figure 1), the difference was less marked after 12 hours (not shown), thus comparisons were made between the 24 hours treated samples and their control. Sixty-one probe sets (representing 54 genes) changed by at least 1.5 fold between the treated samples and their control. Out of the 54 genes 41 were upregulated and 13 downregulated in the Shh treated samples (Table I) .
We next searched for over-represented biological themes among the 54 genes using the 'Ease' program (19) . Functional classifications with an 'Ease score' lower than 0.05 were marked as over-represented. In addition to the 'Smoothened receptor (Hedgehog) signaling pathway', the most significant over-represented biological themes were related to cell motility, angiogenesis and cytoskeletal organization (Table II) . Genes representing these categories are highlighted in table I.
The two genes mostly induced by Shh (after Gli1 and Patched1) were the flavoprotein oxidoreductase Mical2 and Neuropilin1 (Table I) (27, 28) . This family has recently been linked to Semaphorin signal transduction, where they are thought to transmit the signal from the Plexin family transmembrane receptors into the cell and provide the link for regulation of cytoskeletal dynamics (28) . Thus the most significantly induced genes participate in the same pathway which regulates cell migration in response to variety of environmental cues.
We validated the increase in expression of Neuropilin1 and Mical2 by quantitative real time PCR and by immunoprecipitation with RNA and protein derived from new independent experiments (Fig. 4A,B) . The Shh protein used in our experiments is in the form of conditioned media derived from 293T cells transfected with the active N-terminal peptide of Shh. While this approach ensured the formation of properly processed and active Shh protein (29) , the media might have contained other factors that could induce the expression of Neuropilin1 and Mical2 in C166 cells, such as VEGF-A (30). To rule out this possibility we added 10 µM Cyclopamine, a specific inhibitor of the Smoothened receptor -the central transducer of all Hedgehog proteins (24) to our assay. The addition of Cyclopamine abolished the increased expression of Neuropilin1 and Mical2 (Fig.  4A ), proving they were induced by Shh. To further determine the specificity of the response to Shh we generated a bacterially expressed His tagged Shh-N protein (supplementary material Fig. 1 and experimental procedures). This recombinant protein is known to be less active than the protein prepared in mammalian cells, probably due to the lack of posttranslational modifications (29) . As expected, His-Shh-N was less potent in activating the Hedgehog cascade (as exemplified by the limited increase in Patched1 gene expression), but still resulted in an increase of two fold in the expression of Neuropilin1 and Mical2 compared to control (Fig. 4C) 
We next asked whether Neuropilin1 and Mical2 are Hedgehog's endothelial lineage specific transcriptional targets or do they serve as Hedgehog pathway targets in a wider range of cell types. C3H/10T1/2, NIH 3T3 and BALB/c 3T3 are all mouse embryonic fibroblast cell lines known to respond to the Hedgehog signal (17, 23) . In all these cell lines Shh induced the expression of Neuropilin1 and Mical2 (Fig. 4D) , suggesting that Neuropilin1 and Mical2 are induced by Hedgehog in cell lineages other than endothelium.
Shh induces migration of primary cells in-vitro. As C166 and NIH 3T3 are both immortalized cell lines we decided to repeat our assays on primary cells which better reflect the in-vivo physiology. Primary Mouse Embryonic Fibroblasts (MEFs) were tested for Shh induced migration in the wound assay. Not only did stimulation with Shh enhance MEFs migration, but inhibition with Cyclopamine, in 10 µM concentration, depressed MEFs migration to levels below control (Fig. 5A ). This finding implies that the Hedgehog signaling is partially activated in MEFs, and is supported by the Gli1expression studies (done on Shh and Cyclopamine treated MEFs) in which Cyclopamine lowered Gli1 expression below control treatment (Fig. 5B ).
In correlation with these findings, Cyclopamine treatment reduced Mical2 and Neuropilin1 expression levels relative to control treatment, while Shh treatment increased them (Fig. 5B) . Thus, the revealed Hedgehog pro-migratory effect and transcriptional regulation are observed in primary embryonic fibroblasts.
Molecular
pathways mediating Hedgehog induced cell migration. To decipher the role of the neuropillinflavomonoxygenase pathway in mediating the effects of Shh on cell migration, we repeated the in-vitro wound assay using gene silencing and a chemical inhibitor of this pathway.
To study the effects of Neuropilin1 inhibition on Shh induced migration we applied a viral-mediated RNA interference technique (18) for efficient delivery of short interfering RNAs targeting Neuropilin1 gene. A Polyclonal population of C166 cells were generated, infected with Neuropilin1 (Nrp1) silencing retrovirus ('Nrp1 knockdown') or control retrovirus ('Nrp1 CONTORL'). To ensure the specificity of the neuropilin1 shRNA, the control shRNA differed only in five nucleotides from the shRNA targeting neuropilin1. Quantitative real time PCR analysis showed markedly suppressed expression of Neuropilin1 in the 'Nrp1 knockdown' population compared to 'Nrp1 CONTROL', whereas the expression of Mical2 and the closely related molecule Neuropilin2 (Nrp2) was similar in both cell types (Fig. 6A) . We next tested if Neuropilin1 is crucial for the transcriptional regulation seen in C166 following Hedgehog stimulation. Target gene expression analysis indicates that Hedgehog transcriptional regulation was not affected in cells with reduced Neuropilin1 expression (Fig. 6B) , however knockdown of Neuropilin1 dramatically reduced the Shh induction of in-vitro wound repair (Fig. 6B) .
As mentioned before, Mical2, a flavoprotein monooxygenase, has recently been shown to mediate Semaphorin signal transduction involving transmembrane Plexin receptors and resulting in cytoskeletal remodeling (28) . Epigallocatechin gallate (EGCG), a potent inhibitor of flavoprotein monooxygenases (31, 32) , was shown to inhibit the Semaphorin repulsive effect through blocking Mical activity (28) . Based on this information we asked if EGCG can inhibit Shh induced migration in the wound assay. EGCG in concentrations of up to 2.5 µM, shown before to have an inhibitory effect on VEGF induced migration (33), had no effect on C166 proliferation or survival rates (data not shown). EGCG inhibited Shh induced migration in the in-vitro wound assay in a dose dependent manner (Fig. 7A) without affecting the differential expression of Hedgehog target genes (Fig. 7B) . Thus, the promigratory effect of Hedgehog signaling requires both Neuropilin1 and flavoprotein monoxygenases.
Finally, we explored the gene expression data to identify the possible ligand that may bind to Neuropillin1 and mediate the promigratory response to Shh. Analysis of the expression of semaphorins, VEGFs and other known interactors of Neuropilin1 shows that VEGF-B is the Neuropilin1 ligand which has the highest expression in C166 cells. In contrary, semaphorins expression in C166 cells is very low (Table III) .
DISCUSSION
New evidence has emerged supporting a role for Hedgehog pathway in in-vivo wound healing by direct pro-migratory effect on fibroblast and endothelial progenitor cells (13 (36, 37) .
The search for over-represented biological themes among the various hedgehog regulated genes using the 'Ease score' program yielded a group of overrepresented functional classifications related to cell motility, angiogenesis and cytoskeletal organization. The two most significantly induced genes (beside Gli1 and Patched1) -Neuropilin1 and Mical2, participate in regulation of cell migration in response to environmental cues. We have confirmed their induction by Shh by independent experiments in C166 as well as in three other embryonic fibroblasts cell lines and primary embryonic fibrobalsts.
Neuropilin1 serves as a co-receptor for Semaphorin3A, mediating its induction of neural growth cone collapse by forming complexes with the Plexin receptors. In addition Neuropilin1 serves as a co-receptor for VEGF-A, enhancing its pro-migratory effect, mediated by the VEGFR-2 tyrosinekinase receptor, in endothelial cells. A third role for Neuropilin1 is its function as a cell surface adhesion molecule (26) . Knockout of Neuropilin1 in the mouse results in abnormal blood vessel formation including insufficient development of the yolk sac vascular network (38) . Strikingly, this vascular phenotype is virtually identical to the phenotype produced by elimination of Hedgehog signaling in the Smoothened knockout mice.
At later stages of development, Neuropilin1 is preferentially expressed in arterial endothelial cells (39) , and participates in wound angiogenesis, as demonstrated in a murine model of dermal wound repair (40) .
Neuropilin-2 has also been shown recently to induce endothelial cell migration (41) . Since the Hedgehog signal accelerates wound healing in diabetes by increased wound vascularity (13) , neuropillins may play a role in mediating this signal.
Mical2 belongs to a family of multidomain cytosolic proteins with a flavoprotein monooxygenase domain (27, 28) . Flavoprotein monooxygenases are oxidoreducatses that use the flavin adenin dinucleotide (FAD) as a cofactor to insert one atom of molecular oxygen into their substrates. In some contexts these enzymes can act as oxidases and generate reactive oxygen species (ROS) (42) . The Mical proteins, may act as platforms to recruit downstream effectors to the Plexin activation site. The activity of these effectors could then be selectively modulated by redox modifications (42) .
Thus, Mical2 and Neuropilin1 participate in pathways which regulate cell migration in response to variety of environmental cues. We have demonstrated the importance of these genes for the pro-migratory effects of Shh by examining the effects of neuropillin siRNA and of the potent inhibitor of flavoprotein monooxygenases, EGCG. Our findings that Neuropilin1 and Mical2 are Hedgehog transcriptional targets in other cell types than endothelium suggest a more universal role for these molecules in mediating Hedgehog cellular activity.
Neuropillin1 is a co-receptor of semaphorins and VEGFs. VEGFs enhance endothelial cell migration while binding of semaphorins to neuropilin 1 cause regression of neural cells{Eickholt, 1999 #192}. Examination of the gene expression data revealed significant expression of VEGF-B in C166 cells and low to absent expression of semaphorins. VEGF-B has an important role in angiogenesis {Bellomo, 2000 #190} and can bind Neuropilin1 {Makinen, 1999 #191}. The presence of VEGF-B probably explains why the induction of neuropilin 1 by Shh resulted in enhanced cell migration
The Hedgehog pathway has a central role in the pathogenesis of different cancers (4, 5 Few studies have demonstrated that Shh has a critical role in morphogenesis of the aortic arch the cardiac outflow tract (46) (47) (48) . Interestingly, in isl1-cre; smo mutants (in which the Hedgehog signal is ablated within endoderm or adjacent cardiogenic mesoderm) the expression of Neuropilin2, which also participate in Semaphorin signal transduction, is downregulated in the cardiac outflow tract (49) supporting our finding that neuropilins are targets of Hedgehog signaling.
Recent experiments have shown that specialized `tip cells' located at the extremities of capillary sprouts, regulate blood-vessel branching. Tip cells are very similar to growth cones of developing axons, as they seem to regulate extension of the capillary in response to environmental cues in some systems (50). In this study we show that the Hedgehog promigratory effect in the endothelial and fibroblastic lineages may be mediated by molecules that have dual, often opposing, roles in axon guidance and endothelial cell migration. fields showing the wounded area and cell migration into the wound at 'zero' time and after 24 hours, respectively. Both low (x10) and high (x20) magnifications (Magnif.) are shown at 24 hours. Scale bar (for low magnification) = 500 µmeter. (2) Graph shows the percentage of nonrecovered wound area from the intial wound area after 24 hours of migration. B, NIH 3T3 invitro scratch assay. Experiments were conducted the same as for C166 cells. Graph shows the percentage of non-recovered wound area from the initial wound area after 24 hours of migration. Error bars indicate s.d. based on two independent experiments. *P<0.0005, **P<0.05 versus control. Fig. 3. Oligonucleotide microarray outlines. A, a cartoon representing microarray design . Baseline, 12 hours and 24 hours time points, in which RNA was collected from control and Shh treated samples, are illustrated. The microarray methodology is described in detail in 'experimental procedures' section. B, microarray internal controls. Graphs show the fold increase in Gli1 and Patched1 expression upon treatment with Shh (duplicate) relative to control. Gli1 and Patched1 expression is detected both by Quantitative real time PCR (1) and by the genechips' hybridization signal (2) . Axis Y is in logarithmic scale. The difference in the magnitude of Gli1 fold induction between both techniques is due to the genechips' high threshold (low sensitivity) as compared to Quantitative real time PCR and the fact that Gli1 basal expression is very low. 
